Delivery Order SPE2DB24D9105-SPE2DB25FBYVG
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $44,651.52 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 300 mg/2 ml syringes. This firm fixed-price delivery order, issued on September 18, 2025, with an ultimate completion date of October 9, 2025, represents a standard procurement action with no set-aside designation. The award falls under DMS Pharmaceutical Group's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for $6,189.60 to supply Xolair 150 mg/ml syringes. The delivery order, issued on September 8, 2025, with an ultimate completion date of September 29, 2025, carries firm fixed pricing and does not include a set-aside designation. This award is issued under DMS Pharmaceutical Group's larger single-award Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,720.96 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 300 mg/2 mL syringes. This firm fixed-price delivery order, issued on June 2, 2025, is scheduled for completion by June 24, 2025, with performance taking place at the vendor's Park Ridge facility. The award carries no set-aside designation, allowing DMS Pharmaceutical...
- The Defense Logistics Agency awarded a $37.5K firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 300 mg/2 mL syringes. This delivery order, which is expected to be completed by September 11, 2025, was issued without a set-aside designation. DMS Pharmaceutical Group is performing the work at its Park Ridge, Illinois location and will deliver this biologic medication to...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,122.30 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 300 mg/2 ml auto-injector vials. This firm fixed-price delivery order, issued on August 26, 2025, with an ultimate completion date of September 17, 2025, carries no set-aside designation. DMS Pharmaceutical Group is performing at its Park Ridge facility and delivering...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $4,642.20 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 75 mg/0.5 ml syringes. The delivery order, issued on September 18, 2025, with an ultimate completion date of October 9, 2025, carries no set-aside designation. DMS Pharmaceutical Group is executing this order under its larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a $1,547.40 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of XOLAIR 150 mg/ml syringes. The contract is firm fixed-price with an ultimate completion date of September 18, 2025, and carries no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA valued at approximately $500 million...
- The Defense Logistics Agency awarded a delivery order valued at $37,137.60 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 150 mg/ml syringes. This firm fixed-price delivery order, issued on August 26, 2025, carries an ultimate completion date of September 17, 2025, with performance occurring at the vendor's Park Ridge facility. The award was made without a set-aside designation, allowing DMS...
- The Defense Logistics Agency awarded a delivery order valued at $27,907.20 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 300 mg/2 mL syringes. This firm fixed-price delivery order, issued on April 22, 2025, with an ultimate completion date of May 13, 2025, represents a direct procurement without set-aside designation. The award is issued under DMS Pharmaceutical Group's existing Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $3,720.96 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 300 mg/2 mL syringes. This firm fixed-price delivery order, issued on August 21, 2025, is scheduled for ultimate completion by September 12, 2025, with performance taking place at the vendor's Park Ridge location. The award utilizes no set-aside designation, allowing DMS...
- SPE2DB24D9105Indefinite Delivery Contract
- SPE2DB24D9105-SPE2DB25FBYVGDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,860.48 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 300 mg/2 ml syringes. This firm fixed-price delivery order, issued on August 27, 2025, with an ultimate completion date of September 18, 2025, represents a standalone procurement without set-aside designation. The delivery is to be performed in Park Ridge, Illinois, where DMS Pharmaceutical Group maintains its operational headquarters. This award is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499.999 billion vehicle valid through November 2026 that authorizes the issuance of firm fixed-price delivery orders for pharmaceutical products supporting Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group has established itself as a key supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status to provide comprehensive pharmaceutical distribution services including prescription medications, biologics, and medical consumables to military health systems. This particular delivery order for Xolair, a biologic immunosuppressant medication, reflects the company's continued role in supplying specialized pharmaceutical products to DoD healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 8/27/25 |